QuartataWeb
Home  |   About  |   Theory  |   Tutorials  |   FAQ  |   Bahar Lab  |   Statistics

 

Network of interactions between drugs (red spheres) and targets (blue spheres) is displayed above.
The red lines are used for the predicted interactions and the thickness of edges indicate the confidence score of predictions.

Data source: DrugBank-all; Query type: target; # of requested predictions: 20; Secondary interactions: no
Input target 1: P16083
No. Gene UniProt ID Protein Name Pathway PDB
1 NQO2 P16083 Ribosyldihydronicotinamide dehydrogenase [quinone] NA


13 known interactions (drugs) of input target (NQO2): Ribosyldihydronicotinamide dehydrogenase [quinone]
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image
1 Approved;
Nutraceutical;
Vet approved
SmallMoleculeDrug DB01065 Melatonin Thumb
2 Experimental SmallMoleculeDrug DB08744 6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one Thumb
3 Approved SmallMoleculeDrug DB03147 Flavin adenine dinucleotide Thumb
4 Experimental SmallMoleculeDrug DB08190 N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide Thumb
5 Experimental;
Investigational
SmallMoleculeDrug DB04216 Quercetin Thumb
6 Experimental SmallMoleculeDrug DB03541 10-Propargyl-5,8-Dideazafolic Acid Thumb
7 Approved;
Nutraceutical
SmallMoleculeDrug DB00170 Menadione Thumb
8 Approved;
Experimental;
Investigational
SmallMoleculeDrug DB02709 Resveratrol Thumb
9 Experimental SmallMoleculeDrug DB08228 5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one Thumb
10 Experimental SmallMoleculeDrug DB07339 (3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione Thumb
11 Approved;
Nutraceutical
SmallMoleculeDrug DB00157 NADH Thumb
12 Investigational SmallMoleculeDrug DB04253 Tretazicar Thumb
13 Approved SmallMoleculeDrug DB01087 Primaquine Thumb


20 predicted interactions (drugs) of input target (NQO2): Ribosyldihydronicotinamide dehydrogenase [quinone]
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image Confidence score
1 Approved;
Investigational
SmallMoleculeDrug DB11638 Artenimol Thumb 34.8%
2 Approved;
Investigational;
Nutraceutical
SmallMoleculeDrug DB00114 Pyridoxal Phosphate Thumb 31.4%
3 Approved;
Investigational;
Nutraceutical
SmallMoleculeDrug DB00155 L-Citrulline Thumb 29.1%
4 Investigational SmallMoleculeDrug DB05147 CYT997 Thumb 28.5%
5 Approved;
Investigational
BiotechDrug DB00100 Coagulation Factor IX (Recombinant) Thumb 28.5%
6 Experimental;
Illicit
SmallMoleculeDrug DB01561 Androstanedione Thumb 28.3%
7 Experimental;
Investigational
SmallMoleculeDrug DB04090 RH-1 Thumb 27.7%
8 Approved SmallMoleculeDrug DB00780 Phenelzine Thumb 27.2%
9 Approved SmallMoleculeDrug DB09332 Kappadione Thumb 27.0%
10 Approved;
Investigational
SmallMoleculeDrug DB06594 Agomelatine Thumb 25.9%
11 Experimental SmallMoleculeDrug DB04214 4-Nitrophenyl Phosphate Thumb 25.4%
12 Approved;
Investigational
SmallMoleculeDrug DB01136 Carvedilol Thumb 25.4%
13 Experimental SmallMoleculeDrug DB13951 Stanolone acetate Thumb 24.4%
14 Approved;
Investigational
SmallMoleculeDrug DB00980 Ramelteon Thumb 24.2%
15 Approved;
Nutraceutical
SmallMoleculeDrug DB00132 Alpha-Linolenic Acid Thumb 23.6%
16 Experimental SmallMoleculeDrug DB02532 2,4,6-Triaminoquinazoline Thumb 23.0%
17 Experimental SmallMoleculeDrug DB03461 2'-Monophosphoadenosine 5'-Diphosphoribose Thumb 22.8%
18 Approved;
Investigational
SmallMoleculeDrug DB09071 Tasimelteon Thumb 22.5%
19 Approved;
Investigational
SmallMoleculeDrug DB01022 Phylloquinone Thumb 22.1%
20 Approved;
Withdrawn
SmallMoleculeDrug DB04824 Phenolphthalein Thumb 22.0%



  logl

Reference:  Hongchun Li, Fen Pei, D. Lansing Taylor and Ivet Bahar. (2020) QuartataWeb: Integrated Chemical–Protein-Pathway Mapping for Polypharmacology and Chemogenomics. Bioinformatics 36(12), 3935–3937.

Contact:

The QuartataWeb server is maintained by the Bahar Lab at the Department of Computational & Systems Biology at the University of Pittsburgh, School of Medicine, and sponsored by the NIH awards P41 GM103712 and P01 DK096990; and by the Li Lab at Research Center for Computer-Aided Drug Discovery at Shenzhen Institutes of Advanced Technology, CAS.

For questions and comments please contact Hongchun Li.